Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewImaging of gastroenteropancreatic neuroendocrine tumorsThe assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systemsComparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case seriesChemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia.Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayGangliocytic paraganglioma: a multi-institutional retrospective study in Japan.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).A new era for the systemic therapy of neuroendocrine tumors.TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experienceLymph nodes and survival in pancreatic neuroendocrine tumors.Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage.Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.Current concepts on gastric carcinoid tumors.Histopathology of gastrointestinal neuroendocrine neoplasms.Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasmsDiscordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas.Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme.Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
P2860
Q24603675-0D282931-9651-4120-B5C5-BFC50B206D43Q26768483-080566D3-F352-432D-B711-0B3CCDC8E1D4Q28238305-AE180A75-AB9C-417A-81BF-A3F38E950F4AQ30252003-C61CF9A4-31F1-447D-ADE4-07C164EA488DQ30884794-E32E3659-104A-4E24-AC43-9A30EEAB447FQ33514751-DCC57C7F-CA04-4983-AB76-D6C536E026A4Q33591842-78F3A941-4831-452D-B2E8-50C70396E607Q33632569-A10A55B4-B229-4548-9BFD-A59E4DE85CC2Q33753449-A8A902EB-6F06-4330-AE23-260878D5A229Q33779897-C01F9532-7CDA-448B-B879-312B11D37A02Q33783119-82DC13FE-BA69-49DE-B998-593D78560722Q33828850-B170BF26-0B01-48F0-B5CB-457B28FD63D4Q33936290-F7DAC664-2F35-4669-BB49-07035A4343DBQ34049125-2761E76B-2F0A-4FDE-8206-4EB5C3537E2BQ34248466-F73C9046-62B4-447A-AA83-8214A3BCAE27Q34248487-A92210EA-75FF-4D72-BA48-D5F3C74536ECQ34301030-EBB0282B-0D87-4585-A0DE-2F1A111951D6Q34312574-63487B86-F0EA-44DD-B7F7-225BAE56DB37Q34887795-FDC8DD2F-F67F-4B7E-A52B-5E85C9DCBDFEQ35443321-30F1136E-FCC7-4CF8-A9E0-557DA7B79CACQ35760798-6C11738F-1222-4F33-8327-59EAD2FFF780Q35768274-F2DD63B2-44BB-4FC6-80D6-F7AC737F9870Q35771217-10E0DBD0-4DE2-41B3-8ACD-4460F923A443Q35843079-F430E4C3-E29A-4389-851A-060EC3130D66Q35857794-F8FE9412-99D6-4F1F-8A6A-12D22B510A57Q35863865-015E5DE8-331D-45DF-934F-53A5AF0EBBA2Q36009085-DEC1D46B-45F3-4E0B-8001-95A4CB656ABBQ36178121-C5F28CD2-E296-4E06-AF34-F3225DAE82DAQ36250472-1B6493BC-04F6-4CF9-90A3-7D12E6E294DCQ36280303-04D24971-725D-48C7-8893-CB65BA5FBDAAQ36300517-D76AC845-6813-40FB-9F05-B8BE24C31BB4Q36344419-F779964A-5047-4B93-AEF3-5C9D5433D297Q36499917-B99D00DA-FB56-49C8-BA79-6155F2CEE004Q36551032-24E9EB1A-FCBE-4075-99A6-07709A06FE1AQ36831573-04CDF508-B434-4873-8C0F-1A9A743A499BQ36857533-20458226-FAF2-40CF-AB5E-7D6673300F97Q36879154-91D93785-DE46-4B4B-9F47-A3349255BBE1Q36943954-E26EF247-E9DA-44EB-ACBD-0E31620561CAQ37026099-C1E14645-EE95-4D81-875C-C88DDE227F9DQ37056120-3B6658B2-4EC5-4CE5-ABC9-C745816D615C
P2860
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@en
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@nl
type
label
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@en
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@nl
prefLabel
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@en
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@nl
P2093
P50
P356
P1433
P1476
Prognostic relevance of a nove ...... creatic neuroendocrine tumors.
@en
P2093
Angelina Bockelbrink
Bertram Wiedenmann
Henning Jann
Martin Koch
Stefan N Willich
Ulrich-Frank Pape
Uta Berndt
P304
P356
10.1002/CNCR.23549
P407
P577
2008-07-01T00:00:00Z